NVS
Novartis AG ADR
NYSE: NVS · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$153.07
-0.55% today
Updated 2026-06-12
Market cap
$273.77B
P/E ratio
20.59
P/S ratio
4.84x
EPS (TTM)
$6.97
Dividend yield
3.30%
52W range
$109 – $165
Volume
1.5M
Novartis AG ADR (NVS) Insider transactions
Net insider activity
Net selling (17,264,383 shares)
Buy transactions
18
Sell transactions
82
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2020-07-14 | NOVARTIS, PHARMA AG | 10% Owner | Sale | 7,367,387 | — | — |
| 2020-07-14 | NOVARTIS, PHARMA AG | 10% Owner | Buy | 5,908,089 | — | — |
| 2020-06-30 | NOVARTIS, BIOVENTURES LTD | Former 10% Owner | Sale | 199,996 | — | — |
| 2020-06-30 | NOVARTIS, BIOVENTURES LTD | Former 10% Owner | Sale | 856,262 | — | — |
| 2020-06-30 | NOVARTIS, BIOVENTURES LTD | Former 10% Owner | Buy | 856,262 | — | — |
| 2020-06-30 | NOVARTIS, BIOVENTURES LTD | Former 10% Owner | Buy | 199,996 | — | — |
| 2020-06-30 | NOVARTIS, BIOVENTURES LTD | Former 10% Owner | Buy | 125,000 | $17.00 | $2.13M |
| 2020-06-19 | NOVARTIS, BIOVENTURES LTD | Former 10% Owner | Sale | 1,001,312 | $8.25 | $8.26M |
| 2020-06-18 | NOVARTIS, BIOVENTURES LTD | Former 10% Owner | Sale | 900 | $9.04 | $8136.00 |
| 2020-06-17 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 4,622 | $9.27 | $42845.94 |
| 2020-06-16 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 8,600 | $9.30 | $79980.00 |
| 2020-06-15 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 6,164 | $9.05 | $55784.20 |
| 2020-06-12 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 1,500 | $9.19 | $13785.00 |
| 2020-06-11 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 7,200 | $9.21 | $66312.00 |
| 2020-06-10 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 8,532 | $9.46 | $80712.72 |
| 2020-06-09 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 7,000 | $9.38 | $65660.00 |
| 2020-06-08 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 5,659 | $9.66 | $54665.94 |
| 2020-06-05 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 8,652 | $9.66 | $83578.32 |
| 2020-06-04 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 4,088 | $9.55 | $39040.40 |
| 2020-06-03 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 5,208 | $9.78 | $50934.24 |
| 2020-06-02 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 5,669 | $9.68 | $54875.92 |
| 2019-11-12 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 451,609 | — | — |
| 2019-11-12 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 7,200,000 | — | — |
| 2019-11-12 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 9,000,000 | — | — |
| 2019-11-12 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Buy | 3,293,067 | — | — |
| 2019-11-12 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Buy | 250,000 | $12.00 | $3.00M |
| 2019-05-28 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 636,366 | — | — |
| 2019-05-28 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 71,450 | — | — |
| 2019-05-28 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 893,195 | — | — |
| 2019-05-28 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Buy | 893,195 | — | — |
| 2019-05-28 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Buy | 636,366 | — | — |
| 2019-05-28 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Buy | 168,630 | $14.00 | $2.36M |
| 2019-05-28 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Buy | 71,450 | — | — |
| 2019-04-26 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 138,704 | $1.03 | $142865.12 |
| 2019-04-25 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 563,096 | $1.03 | $579988.88 |
| 2019-04-24 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 16,403 | $1.03 | $16895.09 |
| 2019-04-23 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 27,554 | $1.03 | $28380.62 |
| 2019-04-22 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 7,100 | $0.97 | $6887.00 |
| 2019-04-15 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 28,794 | $0.99 | $28506.06 |
| 2019-04-12 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 30,908 | $1.04 | $32144.32 |
| 2019-04-11 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 57,438 | $1.08 | $62033.04 |
| 2019-04-10 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 140,230 | $1.09 | $152850.70 |
| 2019-04-09 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 32,991 | $1.01 | $33320.91 |
| 2019-04-08 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 27,525 | $1.02 | $28075.50 |
| 2019-04-05 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 24,661 | $1.02 | $25154.22 |
| 2019-04-04 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 47,900 | $1.01 | $48379.00 |
| 2019-04-03 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 58,033 | $0.96 | $55711.68 |
| 2019-04-02 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 51,754 | $0.97 | $50201.38 |
| 2019-04-01 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 116,909 | $0.95 | $111063.55 |
| 2019-04-01 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 20,610 | $1.90 | $39159.00 |
| 2019-03-29 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 106,540 | $1.85 | $197099.00 |
| 2019-03-29 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 63,100 | $0.91 | $57421.00 |
| 2019-03-28 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 88,835 | $0.94 | $83504.90 |
| 2019-03-27 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 50,749 | $0.99 | $50241.51 |
| 2019-03-26 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 177,762 | $1.01 | $179539.62 |
| 2019-03-15 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 43,800 | $1.92 | $84096.00 |
| 2019-03-14 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 13,800 | $1.88 | $25944.00 |
| 2019-03-13 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 132,738 | $2.12 | $281404.56 |
| 2018-09-12 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 465,086 | — | — |
| 2018-09-12 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Buy | 2,069,993 | — | — |
| 2018-08-20 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 20,388 | $2.30 | $46892.40 |
| 2018-08-20 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 5,300 | $3.90 | $20670.00 |
| 2018-08-17 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 8,700 | $2.10 | $18270.00 |
| 2018-08-16 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 8,808 | $2.10 | $18496.80 |
| 2018-08-15 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 2,635 | $2.15 | $5665.25 |
| 2018-08-14 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 3,300 | $2.26 | $7458.00 |
| 2018-08-13 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 1,600 | $2.36 | $3776.00 |
| 2018-08-10 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 5,615 | $2.44 | $13700.60 |
| 2018-08-09 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 235 | $2.48 | $582.80 |
| 2018-08-08 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 1,000 | $2.78 | $2780.00 |
| 2018-08-07 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 1,739 | $2.97 | $5164.83 |
| 2018-08-06 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 2,942 | $3.02 | $8884.84 |
| 2018-08-02 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 4,702 | $3.33 | $15657.66 |
| 2018-08-01 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 8,181 | $3.22 | $26342.82 |
| 2018-07-31 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 4,500 | $3.07 | $13815.00 |
| 2018-07-30 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 2,000 | $3.27 | $6540.00 |
| 2018-07-27 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 6,458 | $3.38 | $21828.04 |
| 2018-07-26 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 7,937 | $3.63 | $28811.31 |
| 2018-07-25 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 12,460 | $3.84 | $47846.40 |
| 2018-07-24 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 700 | $4.11 | $2877.00 |
| 2018-07-23 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 30,600 | $4.25 | $130050.00 |
| 2018-07-17 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 12,500 | $4.71 | $58875.00 |
| 2018-07-16 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 300 | $5.15 | $1545.00 |
| 2018-07-11 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 345 | $940.00 | $324300.00 |
| 2018-07-11 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Buy | 663,346 | — | — |
| 2018-06-15 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Buy | 14,449 | — | — |
| 2018-06-13 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 345 | — | — |
| 2018-06-13 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Buy | 720,878 | — | — |
| 2018-05-16 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 345 | — | — |
| 2018-05-16 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Buy | 767,728 | — | — |
| 2018-05-15 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Buy | 274,703 | — | — |
| 2018-05-11 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 19,550 | $10.06 | $196673.00 |
| 2018-05-10 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 22,725 | $10.13 | $230204.25 |
| 2018-05-09 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 51,230 | $10.11 | $517935.30 |
| 2018-05-08 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 26,557 | $10.03 | $266366.71 |
| 2018-05-07 | NOVARTIS, BIOVENTURES LTD | 10% Owner | Sale | 15,548 | $10.11 | $157190.28 |
| 2018-04-23 | NOVARTIS, INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 10% Owner | Sale | 5,214,286 | — | — |
| 2018-04-23 | NOVARTIS, INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 10% Owner | Sale | 1,571,429 | — | — |
| 2018-04-23 | NOVARTIS, INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 10% Owner | Buy | 2,272,726 | — | — |
| 2018-04-23 | NOVARTIS, INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 10% Owner | Buy | 909,090 | — | — |
Frequently asked questions
Are NVS insiders buying or selling?
Over the transactions on record, NVS insiders have been net sellers, with about $13.56M in stock sold across 82 sales, against 3 open-market purchases.
Does insider selling at NVS mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which NVS insiders are selling the most?
Recent selling is concentrated in a few names. NOVARTIS, BIOVENTURES LTD accounts for the largest share on record, with about $13.56M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.